Insights from 2024 EHA Annual Meeting
S

EHA 2024 Insights: Limited Stage HL - Current SOC, Future Directions, and Incorporating BV and Nivo

By Insights from 2024 EHA Annual Meeting FEATURING Steven Park
By Insights from 2024 EHA Annual Meeting FEATURING Steven Park
44 views
July 18, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Related Content

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
10:52
University of Miami Sylvester Comprehensive Cancer Center

Current Treatment of 1L Hodgkin Lymphoma

Feat. C. Moskowitz
12:49
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Treatment of Relapsed HL - Updated Options…

Feat. P. Johnson
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
21:56
Indy Hematology Review

Emerging and Current Treatment for Hodgkin Lymphoma in 2024

Feat. S. Ansell
11:12
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826, a Randomized Study of Nivo-AV…

Feat. A. Herrera
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
16:34
Jennifer Amengual

Top 5 Lymphoma Abstracts From ASH

29:26
Massachusetts General Hospital Cancer Center

Practice-Changing Updates in DLBCL and HL

Feat. J. Erika Haydu
15:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826 - Rationale, Results, and Clin…

Feat. A. Evens
18:24
Memorial Sloan Kettering Cancer Center

Key Lymphoma Updates From ASH

Feat. P. Torka
20:49
SOHO Brazil 2024

Summary of Recent Updates in Advanced Hodgkin Lymphoma

Feat. C. Moskowitz
28:11
Total Health

Hematologic Malignancies Update: Treatment Strategies for AML, DLBCL…

Feat. M. Rotta
10:04
Stephen M. Ansell

NCCN Guidelines for the Treatment of cHL: A New Standard of Care

18:06
SOHO Brazil 2024

Summary of Recent Updates in R/R HL

Feat. C. Moskowitz
26:43
Integrity CE

Treatment Updates and Management of Hodgkin Lymphoma

Feat. A. Niu, D. Wallace, M. Cortese
14:47
Insights from 2024 EHA Annual Meeting

EHA 2024 Insights: Treatment of Advanced Stage, High-Risk Hodgkin&#x…

Feat. M. Salamoon
17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Chronic GVHD: A Case-Based Discussion

Feat. L. Perry
08:59
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "SWOG S1826 Trial - Nivo-AVD vs. Bv-AVD in O…

Feat. S. Rutherford
12:09
Pooja Khandelwal

Treating Fibrosis and Inflammation in GvHD